NEFL and Alzheimer disease: For example, studies have shown that chronic kidney disease can elevate plasma levels of Aβ42, Aβ40, pTau181, pTau217, and NfL, likely due to impaired renal clearance, which raises the risk of falsely diagnosing AD in patients with chronic kidney disease [196,197].